Received Sep 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | FH443 | — |
Bexsero administered instead of MenA vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old female patient who received Men B NVS (Bexsero) (batch number FH443, expiry date 30-SEP-2027) for prophylaxis. Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis. On 15-JUL-2025, the patient received Bexsero. The patient did not receive Menveo. On 15-JUL-2025, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: Bexsero administered instead of MenA vaccine). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-AUG-2025 and 14-AUG-2025 The reporter called to report that a patient had received the Meningococcal B vaccine (Bexsero) instead of the intended Menveo, which had been scheduled for administration on 15 July 2025, which led to wrong vaccine administered. According to the reporter, the patient had been scheduled to receive a dose of the Menveo vaccine later that same day, on 06 August 2025. The healthcare provider had requested safety information regarding the administration of Menveo on 6th August 2025, after one of her patients had mistakenly received Bexsero instead of Menveo on 15th July 2025.